ToddWilliamKelleyMD
Pathology • Salt Lake City, UTHematopathology, Anatomic Pathology, Clinical Pathology
Assistant Professor, Pathology, University of Utah School of Medicine
Are you Dr. Kelley?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 S Chipeta Way
"# Arup"
Salt Lake City, UT 84108Phone+1 801-583-2787Fax+1 801-585-3831
Summary
- Dr. Todd Kelley, MD is a board certified pathologist in Salt Lake City, Utah. He is currently licensed to practice medicine in Utah, Ohio, and Ohio. He is an Assistant Professor at University of Utah School of Medicine.
Education & Training
Ohio State University College of MedicineClass of 2002
Certifications & Licensure
UT State Medical License 2007 - 2026
OH State Medical License 2002 - 2010- OH State Medical License 2002 - 2010
American Board of Pathology Pathology - Anatomic/Pathology - Clinical- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 9 citationsDasatinib overcomes stroma-based resistance to the FLT3 inhibitor quizartinib using multiple mechanisms.Ami B. Patel, Anthony D. Pomicter, Dongqing Yan, Anna M. Eiring, Orlando Antelope
Leukemia. 2020-05-14 - 138 citationsCombining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 MutantsChristopher A. Eide, Matthew S. Zabriskie, Samantha L. Savage Stevens, Orlando Antelope, Nadeem A. Vellore
Cancer Cell. 2019-10-14 - 11 citationsTranscription factor Oct1 protects against hematopoietic stress and promotes acute myeloid leukemia.Jillian L. Jafek, Arvind Shakya, Pei-Yi Tai, Andrea Ibarra, Heejoo Kim
Experimental Hematology. 2019-08-01
